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Summary.-A series of 300 patients presenting consecutively with primary operable
breast cancer has been studied. A significant correlation was found between oestro-
gen-receptor (ER) content and histological grade: the better-differentiated tumours
rarely lacked receptor. This correlation was significant only in women defined as
post-menopausal. Data on early recurrence of disease indicate a worse prognosis
for women in whom primary tumours are ER-.
THERE IS considerable evidence that the
assay of oestrogen receptor (ER) in
metastatic breast tumours helps in pre-
dicting the likelihood of a favourable
response to endocrine therapy (McGuire
et al., 1975). Since cells normally depen-
dent on oestrogen contain a similar
receptor (Jensen et al., 1968; Gorski et al.,
1968) the presence of this protein may
reflect the degree of differentiation of the
cells. If this is true, there should be a
correlation between ER content and other
parameters which assess differentiation,
and in particular with assessment of
tumour grade. A number of reports have
variously stated that there was no signi-
ficant correlation (Johanssen et al., 1970;
Rosen et al., 1975) or that, in a small
number of cases, there may be such a
relationship (Heuson, 1975).
One of the objectives of the present
study was to test this hypothesis, and
another was to determine whether ER
content of the primary tumour is as
valuable in estimating likelihood of early
recurrence as histological grade is reported
to be (Bloom & Richardson, 1957).
AMATERIALS AND METHODS
Patients and Clinical follow-up.-In this
study we have, to date, examined a series of
300 female patients, aged 27-70, presenting
consecutively to the Breast Clinic at the
City Hospital, Nottingham, wvith primary
operable breast cancer. In general, these
patients had tumours < 5 cm in diameter,
not fixed locally, and with no clinical evi-
dence of metastatic spread, thus generally
equating to TNM Stage I arid II breast
cancer. At mastectomy a lymph node was
removed from the low, axillary group, from
the apex of the axilla and from the internal
mammary chain via the second intercostal
space. In all cases the primary tumour
and lymph nodes were examined histologi-
cally, and in most cases part of the primary
tumour was immediately immersed in liquid
N2 and stored for subsequent ER assay.
Patients wrere followed up in a post-
mastectomy clinic by the two surgeons
(R.W.B. and C.J.D.); attendance was at
3-month intervals to 18 months and then at
6-month intervals. Blood analyses of haemo-
globin, wrhite-cell count, erythrocyte sedi-
mentation rate, liver-function tests and
serum calcium were carried out every 6
months. Bone scans writh skeletal surveys
were performed shortly after mastectomy and
then annually.
Recurrence for the purpose of this study
has been defined as:
(i) major local recurrence in the wound
flaps or axillary node enlargement
requiring radiotherapy. Axillary node
enlargement wias not treated unlessP. V. MAYNARD ET AL.
progression caused symptoms (e.g.
pain) and was only defined as re-
currence when treatment commenced.
Isolated minor flap recurrences treated
by cryosurgery or local excision were
likewise excluded from the analysis.
(ii) bone metastases seen on X-ray. A
positive bone scan without visible
metastases on a subsequent X-ray was
not treated, so the time ofdiagnosis of
recurrence was counted from the
appearance on X-ray.
(iii) an enlarged liver with a raised blood
alkaline phosphatase.
(iv) the appearance of lung metastases on
X-ray; (or) the appearance of a
pleural effusion; (or) lymphangitis
carcinomatosa (both the latter con-
firmed by pleural or transbronchial
biopsy).
(v) signs of other distant metastases
(e.g. brain metastases, distant cuta-
neous metastases).
IHistopathology.-Primary carcinoma speci-
mens w%ere fixed in 10% buffered formalin and
blocks taken for section and staining with
Erlich's haematoxylin and eosin. The number
of tumour blocks taken (1-4) depended on
the size of the tumour, having regard to
adequate sampling. The tumours were graded
according to the criteria described by Bloom
& Richardson (1957) by the two pathologists
(C.W.E. and J.J.) independently. Briefly
the tubular differentiation, nuclear pleo-
morphism and nuclear hyperchromatism
and mitotic activity wiere each assessed and
scored from 1-3, (i.e. from good differentiation
and regular nuclei to poor differentiation and
highly atypical nuclei). A composite score
was obtained for each tumour of f'rom 3-9.
Grade I (well differentiated) denotes scores
3, 4 and 5; Grade II (moderately differen-
tiated) scores 6 and 7 and Grade III (poorly
differentiated) 8 and 9. W"here there was
variation wNithin a single tumour the highest
grade present was recorded. The pathologists
agreed on their initial assessment in this
study in 92%o of cases. The remaining 24
tissues wvere reassessed again independently
and agreement was found in 20 cases. There
were only 4 cases which required mutual
consent to report the Grade of the tumour,
and in each disagreement wNas by only one
sub-group.
Fixation and staining techniques for th.e
biopsied lymph nodes were the same as
those used for the tumour. The nodes were
sectioned and examined at several levels.
Any lymph nodes present in the axillary
tail of the mastectomy specimen were also
sectioned. The tumours were staged accord-
ing to presence and site of histologically
confirmed nodal metastases; Stage A-
tumiour confined to breast; Stage B-tumour
present in the low axillary nodes only;
Stage C tumour present in the apical and/
or internal mammary node.
Oestrogen-receptor (ER) assay.- Tissue was
stored in liquid nitrogen until transported
directly by road to the Tenovus Institute,
packed in dry ice. All procedures of the assay
were subsequently perfornied at a tempera-
ture not exceeding 4°C. The tumour tissue
was powdered in the frozen state in a Thermo-
vac tissue pulverizer and a 10-20% (w/v)
homogenate prepared in 10 mm-tris HCI
(pH 7.4) containing 1 mm EDTA and 3 mM
sodium azide. The cytosol was obtained by
centrifugation at 100,000 g for 60 min and its
protein content determined (Lowry et al.,
1951).
Eight portions of the cytosol (200 ul each)
were incubated with an equal volume of
the tris-HCl buffer containing [2, 4, 6, 7-3H]-
oestradiol (sp. act. 96 Ci/mmol) in amounts
ranging from 10-500 pg for 18 h. A suspension
(400 1) of charcoal (0-50% wzN/v) in the tris-
HCI buffer containing gelatin (0-40% w/v) and
Dextran T70 (0.050% w/v) w%as then added
and the tubes agitated for 90 ruin. The char-
coal was precipitated by centrifugation and
the radioactivity in 50 ,ul of the supernatant
determined. An estimate of the binding-site
concentration was made by use of the
Newton-Raphson iterative curve-fitting
technique, using equations derived from the
Law of Mass Action (Feldman, 1972). Non-
specific binding was accounted for by the
inclusion of a saturating concentration of
[3H] oestradiol in one tube, and this was
used as a correction to the other points.
Tumours were considered as ER+ only
when the association constant was > 109
l/mnol and the binding-site concentration
Nwas > 5 fmol/mg cytosol protein.
RESULTS
In the series of 300 patients, data were
not available when the receptor assav was
not performed (41), when tumours were
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TABLE I.-Oestrogen-receptor content and
histological grade in a series of primary
breast tumours
Grade
I II III
Pre-menopausal patients
ER+ 9 17 13
ER- 6 18 17
Post-menopaual patients
ER+ 26* 43* 35
ER- 5 13 47
* Numbers of ER+ and E:F
grades are significantly (P < C
Grade III (X2 test).
classified as intraduct
menopausal status was
Table I shows in the rer
the distribution of recepi
pared with histological g
the data are grouped a
established menopausal
patient. Women were c
menopausal if still mens
plasma sample containe
i.u/1 of FSH, measure
immunoassay technique.
all other women have
post-menopausal. In th
there is a significant cor
receptor content and gr
that when some degree of
tiation is histologically
I and II) there is usuz
specific oestradiol binding
In this series of patient
between receptor content
involvement (tumour st
(Table II).
TABLE II.-Oestrogen-r
and stage ofdisease ai
s
A
Pre-menopausal patients
ER+ 20
ER- 27
Post-menopausal patients
ER+ 52
ER- 34
50
- tumours of these
)-001) different from
'7) or when the
not known (3).
aining 249 cases
tor content com-
trade of tumour:
bccording to the
status of the
lassified as pre-
3truating or if a
3d less than 50
-d by a radio-
For this analvsis
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FIGURE.-Early recurrence rates of 141
patients with oestradiol-receptor-positive
(__ ) and 108 with oestradiol-receptor-
negative ( - ) primary tumours.
The figure shows the percentage of
patients free from recurrence, plotted
according to their ER status, on a life-
table basis. At 18 months of follow-up
there is a significant difference (P < 0 05,
t-test) between the points on the 2 curves.
DISCUSSION
been classed as The data presented support the hypo-
is latter group thesis that the presence or absence of
relation between oestrogen receptor (ER) in the cytosol
rade. It is clear reflects the degree of differentiation of
cellular differen- the cells. The relationship between ER
evident (Grades content and histological grade has been
ally evidence of suggested previously (Heuson, 1975) but
was not found by others (Johanssen etal.,
,s no relationship 1970; Rosen et al., 1975). However, any
and lymph-node correlation of receptor content with more
age) was found detailed histological features remains to
be established. The method of tumour
grading employed has been shown to be of
prognostic significance (Bloom & Richard-
'eceptor content son, 1957) 5-year survival rates being
t mastectomy from 75% in patients with Grade I
;tage tumours to 31% in patients with Grade
tage III tumours. These findings have been
B C confirmed by several investigators (Wolff,
12 7 1966; Champion et al., 1972). An alterna-
8 6 tive grading method of Black et al. (1955)
uses the relatively simple nuclear assess-
34 18 ment of tumour grade. The two methods
19 12 have been found to be comparable in the
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assessment of 5-year survival rates (Eich-
ner et al., 1970). It should be noted that
Black et al. (1955) designate their well-
differentiated tumours Grade 3, i.e. in
reverse numerical order to other methods.
Women with ER-+ tumours, that is
better differentiated tumours, tend to
have a longer time to recurrence (Figure).
Although the definition of recurrence is
not that recommended by UICC, it was
felt that very small minor wound recur-
rences could not justifiably be regarded
as similar to major distant metastases,
and that the analysis was of greater
value as reported. Knowing that ER+
tumours respond better to endocrine
therapy than ER- tumours (McGuire et
al., 1975) and that women who have a
longer disease-free interval are believed to
respond more often to hormone manipula-
tion, the curves in the Figure might have
been anticipated. A recent report (Knight
et al., 1977) although on a smaller series
of patients, also finds curves which are
very similar to those presented here.
However, these workers state that ER
status is an independent prognostic
feature, independent of such criteria as
stage of disease (as also do we: Table II),
tumour site or size, or age of patient;
though no mention was made of tumour
differentiation.
The questions now being investigated
are: (i) whether ER status is of prog-
nostic significance in itself or only in
relation to tumour grade; (ii) whether
ER content is a marker which will help to
modify and make more precise the histo-
logical grading. In particular the clinical
course ofthe disease in women with ER-
or ER+ tumours within Grade II or
Grade III will shed some light on these
problems.
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